These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33227487)

  • 1. Biocompatible copolymer formulations to treat glioblastoma multiforme.
    Erthal LCS; Gobbo OL; Ruiz-Hernandez E
    Acta Biomater; 2021 Feb; 121():89-102. PubMed ID: 33227487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme.
    Erthal LCS; Shi Y; Sweeney KJ; Gobbo OL; Ruiz-Hernandez E
    Sci Rep; 2023 Mar; 13(1):5094. PubMed ID: 36991081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.
    Xing WK; Shao C; Qi ZY; Yang C; Wang Z
    Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and structure-property relationships of an injectable thiol-Michael addition hydrogel toward compatibility with glioblastoma therapy.
    Khan ZM; Wilts E; Vlaisavljevich E; Long TE; Verbridge SS
    Acta Biomater; 2022 May; 144():266-278. PubMed ID: 35296443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
    Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
    J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric drug delivery for the treatment of glioblastoma.
    Wait SD; Prabhu RS; Burri SH; Atkins TG; Asher AL
    Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii9-ii23. PubMed ID: 25746091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
    Affronti ML; Heery CR; Herndon JE; Rich JN; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Bigner DD; Friedman HS
    Cancer; 2009 Aug; 115(15):3501-11. PubMed ID: 19514083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme.
    Darakchiev BJ; Albright RE; Breneman JC; Warnick RE
    J Neurosurg; 2008 Feb; 108(2):236-42. PubMed ID: 18240917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Brandes AA; Tosoni A; Basso U; Reni M; Valduga F; Monfardini S; Amistà P; Nicolardi L; Sotti G; Ermani M
    J Clin Oncol; 2004 Dec; 22(23):4779-86. PubMed ID: 15570079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to chemotherapy of a radiation-induced glioblastoma multiforme.
    Nicolardi L; DeAngelis LM
    J Neurooncol; 2006 May; 78(1):55-7. PubMed ID: 16314941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme.
    Márquez-Rivas J; Ramirez G; Ollero-Ortiz A; Giménez-Pando J; Emmerich J; Quiroga-Cantero E; Rivas E; Gómez-González E
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):e202-6. PubMed ID: 20523247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of carmustine wafers in the treatment of glioblastoma multiforme: a systematic review.
    Zhang YD; Dai RY; Chen Z; Zhang YH; He XZ; Zhou J
    Turk Neurosurg; 2014; 24(5):639-45. PubMed ID: 25269031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current medical treatment of glioblastoma.
    Venur VA; Peereboom DM; Ahluwalia MS
    Cancer Treat Res; 2015; 163():103-15. PubMed ID: 25468228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance.
    Yu F; Li G; Gao J; Sun Y; Liu P; Gao H; Li P; Lei T; Chen Y; Cheng Y; Zhai X; Sayari AJ; Huang H; Mu Q
    Cell Prolif; 2016 Apr; 49(2):195-206. PubMed ID: 26923184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma.
    Giese A; Kucinski T; Knopp U; Goldbrunner R; Hamel W; Mehdorn HM; Tonn JC; Hilt D; Westphal M
    J Neurooncol; 2004 Feb; 66(3):351-60. PubMed ID: 15015668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
    Sage W; Guilfoyle M; Luney C; Young A; Sinha R; Sgubin D; McAbee JH; Ma R; Jefferies S; Jena R; Harris F; Allinson K; Matys T; Qian W; Santarius T; Price S; Watts C
    J Neurooncol; 2018 Jan; 136(2):273-280. PubMed ID: 29139095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].
    Ducray F; Honnorat J
    Presse Med; 2007 Sep; 36(9 Pt 2):1249-54. PubMed ID: 17350791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.
    Dehdashti AR; Hegi ME; Regli L; Pica A; Stupp R
    Neurosurg Focus; 2006 Apr; 20(4):E6. PubMed ID: 16709037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
    Nozhat Z; Heydarzadeh S; Shahriari-Khalaji M; Wang S; Iqbal MZ; Kong X
    Biomater Sci; 2023 Jun; 11(12):4094-4131. PubMed ID: 37073998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.